Terra Tech Corp (OTCMKTS:TRTC) has transformed in recent years to become one of the biggest volume leaders on the entire OTC and one of its most prolific runners exploding from under a dime earlier this year to highs of $0.7455 in April. After a brief respite and shake to the mid $0.20 level TRTC is on fire again racing up the charts towards its previous highs.
TRTC is easily one of the most exciting stocks on the OTC as well as a leader amoungst pot stocks as the only US-based, publicly-traded company that touches every aspect of the cannabis lifecycle—from cultivation, to extraction, to branding and to retail sale. When pot stocks heat up TRTC is a great place to be; they are masters at selling the sizzle on the pot sector and getting themselves featured by mainstream media.
Terra Tech Corp (OTCMKTS:TRTC) is one of the original pot stocks on the OTC led by Derek Peterson “The Public Spokesperson for Medical and Legalized Marijuana.” Investors are excited about the possibility of a more than stellar CC coming on August 15 during which time the Company will announced Q2 results with shareholders.
MCP has been covering TRTC for years; the Company was initially incorporated as Private Secretary, Inc. on July 22, 2008 in the State of Nevada. The Company planned to develop a software program that would allow for automatic call processing through VoIP technology. On January 27, 2012, the Company filed an amendment to its Articles of Incorporation changing its name to Terra Tech Corp and a new pot stock was born.
Derek Peterson is a former Vice President at Morgan Stanley. He left Wall Street because he saw a huge opportunity in medical marijuana. His vision is setting up growing facilities in various states to grow herbs such as basil and thyme with plans to switch to Marijuana production as state laws permit.
TRTC has a number of subsidiaries including Edible Gardens which was established in 2007 and proves fresh, locally grown herbs and leafy greens to supermarkets, restaurants and the food service industry. The growing process utilizes time-tested, classic Dutch hydroponic farming methods to grow produce in a safe and healthy environment.
Another TRTC subsidiary is IVXX Elevate focused on building a recognizable, superior brand that delivers unsurpassed quality and consistency to consumers of recreational and medical cannabis throughout the legal U.S. markets. TRTC has their own lab producing their IVXX branded Marijuana products which are now sold in many California dispensaries.
On June 23 TRTC announced it has expanded its offering of the IVXX Vape Product line with the launch of the “Z92” cartridges, the second line of cannabis oil cartridges. This follows the launch of the Company’s original Z35 cannabis oil cartridge line in April 2016.
Terra Tech’s pre-filled cartridges are offered in a variety of cannabis strains which are easy-to-use and are conveniently designed for vaporizers as well. IVXX Z92 cartridges have a Tetrahydrocannabinol (THC) content level between 75 to 85 percent compared with the 60 to 68 percent of the Z35s. Made from local, sustainably grown cannabis that has been cleanly extracted using supercritical CO2, the oil is lab-formulated for consistency, and lab-tested for purity and potency. Through its low heat refinement technique and a unique filtering method, the Company maintains the natural terpene profile of each strain. There is no reintroduction of terpenes or flavor enhancers at any time in the process, as is true with all IVXX products.
TRTC has an agenda to move to a higher exchange which may necessitate a reverse split and there has been much discussion on this recently. Everyone seems to think that RS is bad and usually results in lower PPS as the result of panic selling etc., but if we really examine the issue we come to an entirely different conclusion. Yes in almost all cases when a non-revenue, sub penny co with a history of dilution does another RS it almost always ends in more downside. At the other end of the spectrum when an established Company such as TRTC that already does significant revenues does a RS it almost always results in significant moves to the upside.
To Find out the inside Scoop on TRTC Subscribe to Microcapdaily.com Right Now by entering your Email in the box below
It is easy to see why pot stocks are on fire again; Four western US states — Alaska, Colorado, Oregon, Washington as well as the nation’s capital Washington D.C. have legalized marijuana for recreational use. An additional 19 states have legalized marijuana for medical use. 2015 was an epic year for the industry; Colorado earned $135 million in taxes and licensing fees on nearly $1 billion in pot sales and the state of Washington took in $70 million on statewide pot revenue totaling $257 million.
Back in March TRTC announced record revenues for the year ended 2015. Total revenues generated for the quarter ended December 31, 2015 were approximately $2.17 million, an increase of 44% from $1.5 million in the same period in 2014; total revenues for the full year 2015 were $9.98 million, an increase of 40.6% from $7.09 million in the year ended December 31, 2014.
TRTC also provided revenue guidance for 2016 calling for $20 million to $22 million. Driving this growth is TRTC’s recently completed acquisition of Black Oak Gallery, DBA: Blüm Oakland, an established, retail medical cannabis dispensary in Oakland, CA. Blüm Oakland, which holds over 42,000 registered patients, has been operating since November 2012 and services close to 1,000 patients each day.
A big part of TRTC recent rise is due to their recent acquisition of Black Oak Gallery, DBA: Blum Oakland, an established, retail medical cannabis dispensary in Oakland, CA which holds over 42,000 registered patients, has been operating since November 2012 and services close to 1,000 patients each day. The acquisition includes Blum’s fully integrated supply chain, which consists of a sophisticated onsite cultivation facility, its portfolio of proprietary strains, as well as its high volume retail storefront. Trailing 12-month non-GAAP revenue for Blum Oakland is over $14 million, which tracks the revenue reported by Blum Oakland in its associated sales tax and marijuana tax reporting and payments.
Western Las Vegas is the first of four retail medical cannabis dispensaries slated to open in Nevada in 2016. Three of those, operating under the store name Blüm, will be in Southern Nevada, on Western Avenue, Desert Inn Road near the Las Vegas Convention Center, and Decatur Boulevard. The fourth is to be located in Reno, in Northwest Nevada. All locations are expected to open in time to take advantage of the very active summer tourism season in Nevada.
(Thanks to Mary777 for this information)TRTC now has two medical marijuana dispensaries up and running, and has three more under construction opening this year, four in Nevada and one in California. THE THIRD IS OPENING ANY DAY.
TRTC plans to acquire more dispensaries in both California, and Nevada, which will more than likely be the next recreational Marijuana states with voting this November. This will bring a major influx of revenue and profit. TRTC’s Blum Oakland dispensary does about $16 million in revenue. Full legalization could double that next year. Factor in other potential acquisitions in Nevada and California, and you will see a HUGE potential for revenue.
TRTC also has future plans for opening other dispensaries around the USA, including Maryland and New Jersey. The BLUM brand could very well turn into the Starbucks of weed once they begin popping up everywhere. Add to that IVXX as a national marijuana brand sold in every state, and every dispensary in the USA, and possibly other countries.
TRTC director Mike Nahass recently purchased a number of domain names such as BLUMCHICAGO.COM, BLUMMANHATTAN.COM, BLUMHOUSTON.COM, BLUMSANDIEGO.COM, BLUMNJ.COM, BLUMNY.COM, BLUMMIAMI.COM as well as dozen more
Nevada is an important market for the cannabis industry as the state will recognize the medical status of non-residents. Nevada also has around 40 million annual visitors with 30% of those coming from California. Recreational marijuana use will be on the Nevada ballot box come November.
We have a Monster Pick Coming. Subscribe Right Now!
Currently trading at a $141 million market valuation TRTC is the only US-based, publicly-traded company that touches every aspect of the cannabis lifecycle—from cultivation, to extraction, to branding and to retail sale. This gives TRTC a huge advantage because they grown their own weed in California and on-site cultivation reduces that cost to about $700 per pound, while the company’s retail price will remain at industry levels 5 to 10 times higher. TRTC is turning into a Revenue leader reporting $9.98 million in sales for 2015 with that number expected to come in way higher this year as TRTC now has two medical marijuana dispensaries up and running, and has three more under construction opening this year. TRTC’s Blum Oakland dispensary does about $16 million alone in revenue. Derek Peterson “The Public Spokesperson for Medical and Legalized Marijuana” is a master at selling the sizzle on the sector and getting their story into the national media spotlight with such news outlets as the Wall Street Journal, National Geographic, Fox Business News, The Huffington Post, the Daily Telegraph and CTV news all covering TRTC in the past. When pot stocks heat up TRTC is the place to be. We will be updating on TRTC when more details emerge so make sure you are subscribed to Microcapdaily so you know what’s going on with TRTC.
Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!
Disclosure: we hold no position in TRTC either long or short and we have not been compensated for this article.